From Early Development into Clinic: De-risking a Bioconjugates Journey

The journey of a novel bioconjugate into clinic is complex and uncertain. In this webinar, we explore the particular challenges when moving a bioconjugate candidate form early development into clinic. Our experts will share key considerations for de-risking this journey. From navigating the divers conjugation technology landscape to designing a robust and scalable process through development. Several customer case studies will illustrate how Lonza’s expertise and integrated solutions have helped drug developers to bring their innovative therapeutics to life.